Glaucoma patients more likely to suffer from hysteria

Article

Patients with open angle glaucoma (OAG) are more likely to have abnormal Minnesota Multiphasic Personality Inventory-2 (MMPI-2) scores in the areas that focus upon concerns of somatic complaints and poor health.

Patients with open angle glaucoma (OAG) are more likely to have abnormal Minnesota Multiphasic Personality Inventory-2 (MMPI-2) scores in the areas that focus upon concerns of somatic complaints and poor health, according to a study published in the December 2007 issue of the Journal of Glaucoma.

Michele Lim from the University of California, Davis, Sacramento, California, USA and colleagues conducted a study to characterize the personality profile of glaucoma subjects. A total of 108 subjects, 56 with OAG and 52 controls, were given the MMPI-2 test, in addition to performing automated perimetry.

Subjects with OAG had significantly higher hypochondriasis, hysteria and health concern scores than the control subjects. OAG subjects also had a significantly greater frequency of clinically abnormal scores for hysteresis and health concerns. Multivariate analysis of variance revealed that hypochondriasis, hysteria and health concerns scores were related to the number of systemic medications used.

The researchers believe that the use of systemic medications may be a constant reminder of illness, perhaps explaining the higher MMPI-2 scores in patients with OAG.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.